About us

ADVAC is an annual two-week training programme for decision-makers, including academia, industry, governmental and non-governmental agencies.

The Course aims to facilitate critical decision-making in vaccinology by providing participants with a comprehensive overview of the various aspects of vaccinology (immunology, vaccine development, clinical trials, regulatory processes, vaccine-specific issues including new vaccines, vaccination strategies and policies, programme implementation, humanitarian emergencies, social, economic, political and ethical issues, financing, and communications…).

 



merieux fondation logo uni ge logo
Organized by Fondation Mérieux & Université de Genève,
at "Les Pensières", Center for Global Health, Veyrier-du-Lac, France, close to Annecy and Geneva.

ADVAC is co-sponsored by:

  • Africa Centres for Disease Control and Prevention
  • Bill & Melinda Gates Foundation
  • Centers for Disease Control and Prevention (CDC)
  • Coalition for Epidemic Preparedness Innovations (CEPI) 
  • European Centre for Disease Prevention and Control (ECDC)
  • European & Developing Countries Clinical Trials Partnership (EDCTP)
  • European Society for Paediatric Infectious Diseases (ESPID)
  • Johns Hopkins Bloomberg School of Public Health
  • International Pediatric Association
  • National Foundation for Infectious Diseases (NFID)
  • National Institutes of Health (NIH/NIAID-USA) and Fogarty International Center
  • World Health Organization

Funding

ADVAC is funded by the participants’ registration fees, education grants, a grant from the Bill & Melinda Gates Foundation (INV-010383) and in-kind contributions from the organizing and co-sponsoring agencies.

Fellowships

For selected ADVAC participants, fellowships are supported by grants funding from the Bill & Melinda Gates Foundation, the European & Developing Countries Clinical Trials Partnership (EDCTP) and the European Society for Paediatric Infectious Diseases (ESPID).

Sponsors providing education grants for ADVAC 2023
Coalition for Epidemic Preparedness Innovations • GlaxoSmithKline • Janssen Vaccines & Prevention B.V. • Merck • Moderna • Pfizer • Sanofi • Serum Institute of India • Takeda